Learn how the University of Alabama is taking a dogged approach to studying new brain tumor therapies.
PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to […]
We have a lot to gain from accelerating the adoption of NGS testing. The technology exists, but that’s only half the battle. The right approach matters too. Learn more by attending our informative webinar on April 24.
PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of Medical Genetics and Genomics (ACMG) a series of enhanced germline […]
PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report […]
Learn how cardiologists are bringing precision medicine to their patients.
Learn how TriCore Reference Laboratories will use the Clinical Genomics WorkSpace (CGW) from PierianDx to accelerate NGS testing.
Learn more about All of Us, the landmark study being launched by the NIH, and why we need solutions for streamlining genetic analysis.
Learn more about the predictive phenotyping study being launched by Inova and the NIH.
The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Working with our customers, we’ve established some best practices and will discuss them at the upcoming Executive War College.